These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 19784895

  • 1. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event? A case report].
    Krzyzanowski K, Michałkiewicz D, Wierzbowski R, Gniłka A, Ryczek R, Orski Z, Kubik L.
    Kardiol Pol; 2009 Aug; 67(8):927-9. PubMed ID: 19784895
    [Abstract] [Full Text] [Related]

  • 2. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event?].
    Oreziak A, Przybylski A.
    Kardiol Pol; 2009 Aug; 67(8):930-1. PubMed ID: 19885986
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T, Hochadel M, Strauss M, Skarlos A, Seidl K, Zahn R.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [Abstract] [Full Text] [Related]

  • 6. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B, Schernthaner C, Pichler M.
    Int J Cardiol; 2005 Jul 10; 102(2):363-6. PubMed ID: 15982515
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
    Kazmierczak J, Tavernier R, De Sutter J, Jordaens L.
    Pol Merkur Lekarski; 2000 Aug 10; 9(50):522-6. PubMed ID: 11081315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Shocking truths about implantable cardioverter defibrillator monitoring zones.
    Mansour F, Thibault B, Dubuc M, Guerra PG, Macle L, Brugada R, Roy D, Talajic M, Khairy P.
    Pacing Clin Electrophysiol; 2007 Sep 10; 30(9):1146-8. PubMed ID: 17725760
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic capabilities of devices for cardiac resynchronization therapy.
    Gardini A, Lupo P, Zanelli E, Bisetti S, Cappato R.
    J Cardiovasc Med (Hagerstown); 2010 Mar 10; 11(3):186-9. PubMed ID: 19829134
    [Abstract] [Full Text] [Related]

  • 11. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
    Vollmann D, Lüthje L, Zabel M.
    Heart Rhythm; 2009 May 10; 6(5):718-9. PubMed ID: 19303370
    [No Abstract] [Full Text] [Related]

  • 12. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM, Sharma S, Dougherty AH, Kantharia BK.
    Cardiol J; 2009 May 10; 16(5):473-6. PubMed ID: 19753529
    [Abstract] [Full Text] [Related]

  • 13. Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy.
    Theuns DA, Klootwijk AP, Simoons ML, Jordaens LJ.
    Am J Cardiol; 2005 Jan 15; 95(2):271-4. PubMed ID: 15642568
    [Abstract] [Full Text] [Related]

  • 14. Inappropriate shock due to late dislocation of electrode.
    Ruiz-Salas A, Datino T, Peña-Hernández J, Calvo D, Alzueta J.
    Int J Cardiol; 2015 Nov 15; 199():229-31. PubMed ID: 26209824
    [No Abstract] [Full Text] [Related]

  • 15. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
    van den Berg MP, van Tintelen JP, van Dessel PF, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2004 Oct 23; 148(43):2132-5. PubMed ID: 15553359
    [Abstract] [Full Text] [Related]

  • 16. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators.
    J Am Coll Cardiol; 2008 Apr 08; 51(14):1357-65. PubMed ID: 18387436
    [Abstract] [Full Text] [Related]

  • 17. Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
    Gersh B.
    Nat Clin Pract Cardiovasc Med; 2004 Nov 08; 1(1):16-7. PubMed ID: 16265252
    [No Abstract] [Full Text] [Related]

  • 18. Inappropriate shock despite successful termination of supraventricular tachycardia by antitachycardia pacing during charging.
    Bernier M, Essebag V.
    Pacing Clin Electrophysiol; 2010 Sep 08; 33(9):e81-3. PubMed ID: 20230474
    [Abstract] [Full Text] [Related]

  • 19. [Atrial defibrillator].
    Jung W, Lüderitz B.
    Z Kardiol; 2000 Sep 08; 89 Suppl 3():206-14. PubMed ID: 10810804
    [Abstract] [Full Text] [Related]

  • 20. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.
    Kanoupakis EM, Manios EG, Kallergis EM, Mavrakis HE, Goudis CA, Saloustros IG, Milathianaki ME, Chlouverakis GI, Vardas PE.
    J Am Coll Cardiol; 2010 Jun 15; 55(24):2753-9. PubMed ID: 20538169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.